Last reviewed · How we verify
NCT06612242
Early vs. Late Tracheostomy in Patients With Guillain -Barre Syndrome
trial testing early tracheostomy (less than 7 days from intubation) in Guillain Barre Syndrome in 30 participants. Currently enrolling.
1 January 2027
Quick facts
| Lead sponsor | Meir Medical Center |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 1 February 2025 |
| Primary completion | 1 January 2027 |
| Estimated completion | 1 January 2027 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- early tracheostomy (less than 7 days from intubation)
- Late tracheostomy (more than 7 days from intubation)
Conditions studied
- Guillain Barre Syndrome — all drugs for Guillain Barre Syndrome →
- Mechanical Ventilation — all drugs for Mechanical Ventilation →
Sponsor
Meir Medical Center
Who can join
18 and older, any sex, with Guillain Barre Syndrome or Mechanical Ventilation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Tracheostomy is one of the most common procedures in the intensive care unit in patients who need prolonged invasive mechanical ventilation. There is controversy in the literature regarding the ideal timing for performing tracheostomy in critically ill patients. Early tracheostomy may be associated with a decrease in ventilation days and hospitalization. We would like to investigate whether in ventilated patients with Guillain Barre syndrome, early tracheostomy will be associated with decreased ventilation days, decreased mortality and shorter hospital and ICU length of stay.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06612242
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Meir Medical Center trials
Trials by the same sponsor.
- NCT07256886 — Validation of the iCVS Model in Patients Admitted to the Intensive Care Unit · not yet recruiting
- NCT07315477 — Characteristics of Patients Intubated for Airway Protection in the Intensive Care Unit and Timing of Tracheostomy · not yet recruiting
- NCT07183410 — Impact of Blood Cultures Drawn From Arterial Lines on the Incidence of Contamination, Detection of Bacteremia, and Blood · not yet recruiting
- NCT07256860 — Influence of Chest X-ray vs. Chest CT Scan on the Management of ICU Patients With Respiratory Failure · not yet recruiting
- NCT05784350 — Preoperative Point of Care Ultrasound Guided Fluid Optimization and Intravenous Ondansetron to Prevent General Anesthesi · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06612242 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Meir Medical Center
- Last refreshed: 13 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06612242.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing